课题基金 / 基金详情

COLLABORATION OF GROWTH FACTOR AND ONCOGENE PRODUCT IN HEPATOCARCINOGENESIS AND LIVER REGENERATION -ANALYSIS BY DOUBLE TRANSGENIC MICE-

COLLABORATION OF GROWTH FACTOR AND ONCOGENE PRODUCT IN HEPATOCARCINOGENESIS AND LIVER REGENERATION -ANALYSIS BY DOUBLE TRANSGENIC MICE-
生长因子和癌基因产物在肝癌发生和肝脏再生中的协同作用-双转基因小鼠分析-
批准号:
09670510
负责人:
TAKAGI Hitoshi
金额:
$2.18万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1997
资助国家:
日本
项目状态:
已结题
起止时间:
1997 至 1998

项目摘要

项目成果

TAKAGI Hitoshi的其他基金

相似基金

相关文献

中文摘要
翻译
转化生长因子α和原癌基因ras通过激活酪氨酸激酶参与细胞内信号转导。我们和其他小组分别建立了转化生长因子α转基因小鼠(T)和ras转基因小鼠(R),这两种转基因小鼠都表现出肝细胞癌、胰腺纤维化(T)和脾肉瘤和皮肤乳头状瘤(R)等特征性表型。我们制作了TGFα和ras(T+R)双转基因小鼠,并对其表型、成瘤和肝再生进行了分析。首先,T+R组的体重和肝脏重量比T和R组低。T+R组出生后体重显著高于单纯T组和R组,出生后12个月有4例出现大肝癌和腺瘤。15例(R)中有4例发生皮肤乳头状瘤,15例(T)中有2例发生双肝腺瘤。T+R组和T+R组的肝细胞增殖细胞核抗原阳性率均在10%以上,T+R组的非肿瘤组织中约有1%的细胞增殖细胞核抗原染色阳性,而非肿瘤性肝组织仅有不到1%的增殖细胞核抗原表达。T+R组胰腺重量大于T或R组,胰腺纤维化程度高于T或R组,TGFa和ras同时过表达抑制小鼠生长,促进肝脏生长,促进肝肿瘤的形成和再生。TGFα和ras也可促进胰腺纤维化,从而促进胰腺生长。
英文摘要
Transforming growth factor(TGF)alpha and protooncogene ras are involved inthe intracellular signal transduction through the activation of tyrosine kinase.We and other group have developed TGFalpha transgenic mice(T) and ras transgenicmice(R) independently, Both of the transgenic mice showed characteristicphenotypes e.g. hepatocellular carcinoma, pancreatic fibrosis for (T) andsplenic sarcoma and skin papilloma for (R). We made the double transgenic miceof TGFalpha and ras(T+R) and analyzed the phenotype, tumor formation, and liverregeneration. First of all, T+R had lower body weight than T and R and the rate ofliver weight! body weight was significantly higher in T+R than single T or R.Large hepato cellular carcinoma and adenoma were observed in 4 of 15 T+R 12months after birth. Four of 15(R) developed skin papilloma and 2 of 15 (T) didhepatic adenoma. More than 10% of hepatocytes were positively stained byproliferating cell nuclear antigen(PCNA) in liver tumors of T+R and about 1% ofnon-tumor tissue of T+R.On the other hand, non-tumor liver showed less than1% by PCNA.Compared with T and R, T+R showed enhanced regeneration of theliver after 2/3 hepatectomy. Skin tumor and splenic sarcoma was not enhancedin T+R compared with R.he weight of pancreas was heavier in T+R than T or Rand pancreatic fibrosis was enhanced in T+R than T or R.Thus simultaneous overexpression of TGFa and ras inhibited the growth ofthe mice and enhanced the growth of the liver, hepatic tumor formation andregeneration. Pancreatic fibrosis was also enhanced by TGFalpha and ras, resultingin enhanced growth of pancreas.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Takayama H,et al: "Analysis of the hepatic and gastrointestinal phenotype of HGF/SF transgenic mice.(in Japanese)" Frontiers in Gastroenterology. 2. 252-260 (1997)
Takayama H 等人:“HGF/SF 转基因小鼠的肝脏和胃肠道表型分析。(日语)”胃肠病学前沿。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Takagi H, et al: "Steroid hormone-dependent overexpression of cytochrome p450 2A in liver tumor of TGFα transgenic mice." J Gastroenterol. 32. 708-711 (1997)
Takagi H 等人:“TGFα 转基因小鼠肝脏肿瘤中细胞色素 p450 2A 的类固醇激素依赖性过度表达。” J Gastroenterol。 32. 708-711 (1997)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
30
    Development of low-cost extraction method for cellulose nanofiber from paper sludge and application to biocomposites
    • 批准号:
      24656394
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.58万
    • 财政年份:
      2012
    • 负责人:
      TAKAGI Hitoshi
    • 依托单位:
    Clinical evidence-based investigation of developmental mechanism in diabetic retinopathy
    • 批准号:
      23592594
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.16万
    • 财政年份:
      2011
    • 负责人:
      TAKAGI Hitoshi
    • 依托单位:
    Development of nano cellulose fiber green composites fabricated by combining controlled solidification and freeze-drying
    • 批准号:
      20560642
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.08万
    • 财政年份:
      2008
    • 负责人:
      TAKAGI Hitoshi
    • 依托单位:
    Combination therapy of apoptosis induction and molecular targeting for hepatocellular carcinoma. -Transgenic mice study-
    • 批准号:
      15590619
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.92万
    • 财政年份:
      2003
    • 负责人:
      TAKAGI Hitoshi
    • 依托单位:
    国内基金
    海外基金
    金荞麦黄酮靶向抑制c-MET介导的PI3K/Akt和Ras/MAPK通路逆转NSCLC EGFR-TKI耐药的机制研究
    • 批准号:
      2026JJ81256
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      李弘德
    • 依托单位:
    槲皮素基于P53/Ras调控细胞凋亡增殖抗OSF癌变的机制研究
    • 批准号:
      2026JJ82512
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      王韧
    • 依托单位:
    lncRNA H19通过介导Ras/ULK1信号影响乳腺癌细胞线粒体稳态及糖酵解的作用及机制研究
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
      施文标
    • 依托单位:
    新型污染物三(2-氯丙基)磷酸酯通过RAS/NLRP3信号通路致肾纤维化机制研究
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
      李升
    • 依托单位: